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Sodium alginateAbstract The object of the present study is to evaluate the effect of application of low-substituted
hydroxypropyl cellulose (L-HPC) 11 and B1 as excipients promoting ﬂoating in gastroretentive
tablets. Directly compressed tablets were formed based on experimental design. Face-centred central
composite designwas applied with two factors and 3 levels, where amount of sodium alginate (X1) and
L-HPC (X2) were the numerical factors. Applied types of L-HPCs and their 1:1 mixture were included
in a categorical factor (X3). Studied parameters were ﬂoating lag time, ﬂoating time, ﬂoating force,
swelling behaviour of tablets and dissolution of paracetamol, which was used as a model active
substance.Due to their physical character, L-HPCs had different water uptake and ﬂowability. Lower
ﬂowability and lower water uptake was observed after 60 min at L-HPC 11 compared to L-HPC B1.
Shorter ﬂoating times were detected at L-HPC 11 and L-HPC mixtures with 0.5% content of sodium
alginate, whereas alginate was the only signiﬁcant factor. Evaluating results of drug release and
swelling studies on ﬂoating tablets revealed correlation, which can serve to help to understand the
mechanism of action of L-HPCs in the ﬁeld development of gastroretentive dosage forms.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of the King Saud University. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
3.0/).1. Introduction
Floating drug delivery systems belong to the group of gastrore-
tentive dosage forms ﬁrstly described by Davis in 1968 (Davis,
1968). These dosage forms are able to achieve prolonged gastric
residence time with increased period for active pharmaceutical
ingredients (API) to be released. Action can be local for treatment
of the stomach or may be systemic. In the development of ﬂoating
dosage forms, two different technologies are applied based on
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non-effervescent approaches have been discussed by Singh et al.
(Singh and Kim, 2000). In our experiments, effervescent ﬂoating
tablets (EFT) were prepared based on sodium alginate as a swell-
ing agent and sodium hydrogen carbonate generating carbon
dioxide in the acidic media. During the swelling of sodium algi-
nate, carbon dioxide is entrapped in a hydrating gel frame lead-
ing to drop of internal density, which leads to the buoyancy of
the preparation. One of the most important aims of application
of ﬂoating drug delivery systems is the fact that several drugs
have only narrow absorption window in the gastrointestinal
tract, which raises difﬁculties during the enhancement of the bio-
availability. Prolonged gastric residence is also reasonable for
drugs which are unstable in the lower section of the gastrointes-
tinal tract or having poor absorption from intestines (Srivastava
et al., 2005). In our experiments, sodium alginate ﬂoating matrix
tablets were produced by simple direct compression.
Mechanisms of different types of disintegrants applied in
ﬂoating tablets have various effects including swelling, parti-
cle repulsion as well as gas generation (Rudnic et al., 1982).
Low-substituted hydroxypropyl cellulose (L-HPC) is a widely
used disintegrant in direct compression of tablets and granu-
lation as well. Applied concentration is generally between
2.5% and 5.0% (Kawashima et al., 1993a,b). Its disintegrat-
ing effect is due to its rapid and intense water uptake and
swelling, in which the dominant parameter is the particle size
described by Kawashima et al. (1993a,b) as well as shape of
particles controlling the process of disintegration.
Another commonly applied excipient in gastroretentive
tablets is sodium alginate, which is a non-toxic, biodegrad-
able co-polymer composed of L-guluronic and D-mannuronic
acid blocks (Whitehead et al., 1998) derived from brown
seaweed species and extracted by the ion-changing technique
(Miller, 1996). Sodium alginate also hydrates and swells in
aqueous media, however in acidic medium insoluble alginic
acid is formed which contributes to the buoyancy.
In the present study the nonsteroidal anti-inﬂammatory drug
(NSAID), paracetamol was used as a model API, which is a
widely applied analgesic and antipyretic agent, acting by the
inhibition of COX 3 enzyme (Botting and Ayoub, 2005). Para-
cetamol is highly metabolized, its mean plasma half-life is 2 h
in healthy adults (Thomas, 1993), therefore preparation of a
ﬂoating drug delivery system containing paracetamol is also rea-
sonable. Its solubility is high, 20.2 mg/ml in 0.1 M HCl, there-
fore its dissolution from matrix tablets is considered to be
independent from solubility properties (Obeidat et al., 2010).
In the present study EFTs were prepared according to an
experimental design including categorical face-centred central
composite set-up with two numeric factors (concentration of
sodium alginate and L-HPC) having three levels with one
centre point. To accomplish the difference between L-HPC
types, categorical factor was introduced, including the two
types of L-HPC applied and their 1:1 mixture. Linear, qua-
dratic and cubic ﬁtting models were assessed on the responses
in order to ﬁnd the best model to evaluate the results.
2. Materials and methods
2.1. Materials
Paracetamol (Molar Chemicals, Hungary) was used as a model
drug substance. High viscosity sodium alginate (Hungarophar-ma, Hungary) was used as the swelling excipient promoting
ﬂotation. Viscosity of the applied 1% sodium alginate solution
was 213.80 ± 0.83 mPas measured at 100 s1 shear rate with
Anton Paar Rheolab QC viscometer at 30 C. Low substituted
hydroxypropyl cellulose B1 (Egis Pharmaceuticals PLC, Hun-
gary) and 11 (Egis Pharmaceuticals PLC, Hungary) were used
as disintegrants. Sodium bicarbonate (Molar Chemicals, Hun-
gary) was used as effervescent agent. Talc, magnesium stea-
rate, microcrystalline cellulose and silica colloidal anhydrous
were used as excipients for tablet compression (Hungarophar-
ma, Hungary).
2.2. Comparative physical examination of L-HPC 11 and L-
HPC B1 disintegrants
2.2.1. Microscopic examination
Microscopic examination at 160· and 640· magniﬁcation
(Zeiss, Axio Imager A1 Microscope, Germany) was performed
to measure particle size and shape parameter of the two differ-
ent types of L-HPCs by using a 5 megapixel microscopic cam-
era (Zeiss AxioCam MRc 5, Germany). For particle size
examination 50 largest separated particles were measured.
Sphericity (W) was calculated by the following formula:
W ¼ 4p Af
P2Cr
ð1Þ
Sphericity of particles describes the form of region on the
bases of their circularity. Numerically range is from 0 to 1.
The value of the sphericity for a perfect round shape particle
is 1. Filled area (Af) is the region including any holes on it.
Crofton perimeter (PCr) determines circular region with cor-
rection, which is optimized for circular objects. For digital
photo analysis Zeiss Axio Vision Rel. 4.7 software (Carl Zeiss,
Germany) was used.
2.2.2. Flowability
Differences in ﬂow properties of the types of L-HPCs were
examined to highlight further physical dissimilarities. Determi-
nation of angle of repose was carried out according to 2.9.16.
test of Ph. Eur. 5.0. During the examinations ASTM standard
funnel was used having 111 mm height and 10 mm size of ori-
ﬁce. The funnel was ﬁxed 4 cm above a glass plate. Measure-
ment was carried out in triplicate. Angle of repose was
calculated by the following formula (USP, 2007):
tgðaÞ ¼ H
R
ð2Þ
where, a is the angle of repose, H is the height above the glass
plate, and the R is the radius of the conical pile. Result was con-
sidered to be valid, when symmetric cone shape was formed.
Apparent density examination was carried out by a volu-
metric device (Erweka SVM 121, Germany) according to
2.9.15. Ph. Eur. 5.0. During the experiments tapped and bulk
densities were calculated. 100.0 g L-HPC types were ﬁlled into
a dry graduated cylinder, after which the cylinder was locked
on a tapping platform performing 10, 500, and 1250 taps. Bulk
densities (qbulk) were recorded after ﬁlling into graduated cylin-
der; tapped densities (qtapped) were recoded after 1250 taps
referred to 100.0 g sample. Using these measurements Carr
index (Ci) (Carr, 1965) was calculated according to the follow-
ing formula:
660 P. Dio´s et al.Ci ¼
qtapped  qbulk
qtapped
 100 ð3Þ
Hausner ratio (Hr) was also determined by using ratio
between tapped and bulk density of powders applying the fol-
lowing formula:
Hr ¼
qtapped
qbulk
ð4ÞTable 1 Levels and real values of experimental design.
Levels of factors 1 0 1
Concentration of sodium alginate, X1 (%) 0.50 17.82 35.15
Concentration of L-HPCs, X2(%) 0.50 12.75 25.00
Table 2 Experimental layout of categorical face-centred
central composite design(X3).
Exp. No. Sodium alginate L-HPC 11
PFS01 1 1
PFS02 1 1
PFS03 1 1
PFS04 1 1
PFS05 1 0
PFS06 1 0
PFS07 0 1
PFS08 0 1
PFS09 0 0
Exp. No. Sodium alginate L-HPC B1
PFS10 1 1
PFS11 1 1
PFS12 1 1
PFS13 1 1
PFS14 1 0
PFS15 1 0
PFS16 0 1
PFS17 0 1
PFS18 0 0
Exp. No. Sodium alginate L-HPC 11/B1 (1:1)
PFS19 1 1
PFS20 1 1
PFS21 1 1
PFS22 1 1
PFS23 1 0
PFS24 1 0
PFS25 0 1
PFS26 0 1
PFS27 0 02.2.3. Wettability
Force tensiometer (KSV, Sigma 701) was used to evaluate
water uptake of the applied HPCs. Glass sample holder vessel
was applied with 1.15 mm width and with 1.00 mm diameter
glass ﬁlter at the bottom holding 50.0 mg of samples, immersed
into distilled water and 0.1 M hydrochloric acid with 0.5 mm
immersion depth for 60 min. Sampling was done every 5 s.
Accuracy of force tensiometer instrument was 0.01 mg. Wetta-
bility tests were performed in triplicate.
2.3. Preparation of ﬂoating tablets
2.3.1. Experimental design
Central composite design was implemented to view the differ-
ence of two types of L-HPCs in dissolution and ﬂoating prop-
erties of tablets. The design contained two numeric factors (X1,
X2) with three-levels (1, 0, +1) in a face-centred central com-
posite set-up (a= 1) with one centre point. One categorical
factor was also applied including the types of two L-HPCs
and their 1:1 mixture (X3). Each experimental composition
had two independent variable ingredients: the concentration
of sodium alginate (X1) and the particular L-HPCs (X2).
Sodium alginate and L-HPC content is shown in Table 1.
Table 2 represents the 9 possible combinations for the third,
categorical factor (X3). Each tablet contained 150 mg paracet-
amol and ﬁxed amounts of excipients contributing the ﬂoata-
tion and tablet compressing ability. Examined variables were
the following: ﬂoating time, ﬂoating lag time, ﬂoating force,
swelling capability and drug dissolution.
2.3.2. Production of ﬂoating tablets
Tablet ingredients were accurately weighed on analytical bal-
ance (Kern, ABJ 220-4M, Germany). Mixing of the powders
was performed every time after adding next substance for
3 min using mortar and pestle, and ultimately all the blends
were blended for 10 min. The ﬂow property of ﬁnal mixtures
was qualiﬁed to be suitable for direct compression applying
eccentric single-punch tablet press (Erweka, EP-1, Germany)
using 8, 10, 12 mm round concave punches.
2.3.3. Determination of ﬂoating time and ﬂoating lag time
Floating time (tf) is the time, during which the sample tablet
ﬂoats on the surface of the examined medium, ﬂoating lag time
(tlag) is period from the immersion of the tablet until its buoy-
ancy. Before starting experiments, tablets were stored for 24 h
in a desiccator. Parameters tf and tlag were studied at
37 ± 0.5 C in 450 ml hydrochloric acid (pH = 1.2) in tripli-
cate. Duration of buoyancy and lag time was visually recorded
by a camcorder (Sony, DCR-SX85E). Each test was carried
out for 4 h.2.3.4. Determination of swelling capability
Swelling capabilities of ﬂoating tablets were examined in trip-
licate, according to the method described by Dorozynski et al.
(2004). Tablet weights were measured (W1) then immersed into
a glass beaker ﬁlled with 200 ml of 0.1 M hydrochloric acid.
Temperature was maintained at 37 ± 0.5 C. At time 30, 60,
120, 180 and 240 min, tablets were removed from the beaker
and reweighted (W2) after wiping the excess liquid from its sur-
face. Swelling index (Si) was calculated by the following
formula:
Si ¼ ðW2 W1Þ
W1
ð5Þ
Calculated index was corrected with the actual tablet
weight in order to standardize the results. Swelling study was
performed only on tablets having no rapid disintegration.
2.3.5. Study of ﬂoating forces
Floating force study was carried out based on the theoretical
background described by Timmermans and Moes (1989,
Figure 1 Structure of standard vessel and ﬁltering plate for ﬂoating force test.
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force tensiometer (KSV Instruments Ltd., Helsinki, Finland)
was applied, which is a precision scale with 0.1 mg accuracy.
Tablets ﬂoated in a standard vessel containing 450 ml 0.1 M
hydrochloric acid, in which a special ﬁltering plate with
2 mm aperture size was immersed (Fig. 1). Majority of devel-
oping carbon dioxide bubbles passed through the ﬁlter result-
ing in less noise during the measurement. Media were treated
with ultrasound to avoid gas formation on ﬁltering plate.
During the test, the weight of the ﬁltering plate was contin-
uously measured. EFTs pushed the ﬁltering plate upward, thus
change of the weight could be detected in function of time. Eval-
uation contained the determination of the maximal ﬂoating
force (Fmax), time (tFmax) needed for maximal ﬂoating force
and time (tF1/2), which is required for 50% of maximal ﬂoating
force.
Floating forces were calculated based on description by
Cromer (1981):
Ffloat ¼ F0  Ft ¼ F0 mt  g ¼ F0  ðF0 þmit  gÞ ð6Þ
In the formula above Fﬂoat is the ﬂoating force expressed on
the ﬁltering plate by a tablet. F0 equals the multiplication of ﬁl-
tering plate mass in medium with gravitational acceleration
(g), which was constantly 39.84 mN. mt is the weight measured
by the devices when a tablet pushed the plate upward. mit is the
negative weight gradient caused by the tablet directly, which
was calculated by subtraction of mt from m0. In absolute value,
mt is the weight expressed by the buoyancy of EFT tablets. All
experiments were done in triplicate.
2.3.6. Paracetamol release study
Release studies were performed according to Ph. Eur. 2.9.3 dis-
solution test with paddle apparatus at 50 rpm speed (Erweka,
DT 700, Germany). Dissolution media were 900 ml artiﬁcial
gastric acid juice (0.1 MHCl) and were kept at 37 ± 0.5 C. Dis-
solution tests were carried out for 4 h, due to the motoric activity
of the stomach, which starts in fed state generally after 2–6 h
after food intake, but more typically after 3–4 h. These peristal-
tic contractions are similar to the second phase of interdigestive
myoelectric motor complex (IMMC) occurring in fasting state
(Davis, 1990; Klausner et al., 2003; Oth et al., 1992; Stops
et al., 2006a,b). During the release study, 2.5 ml samples were
taken automatically at 5, 10, 15, 20, 30, 45, 60, 90, 120, 180
and 240 min after ﬁltration through PTFE membrane ﬁlter.Paracetamol content was measured by a UV/VIS spectro-
photometer (Jasco V-670, Japan) on the absorption maximum
of the drug substance at 243 nm. Paracetamol concentrations
were calculated according to a linear calibration curve
(R2 = 0.9997) which was measured between 0 and 25 mg/l con-
centration. All samples were measured in this concentration
interval.
2.4. Statistical analysis
Evaluations of our measurements were carried out by Design
Expert 7.0.0 software (Stat-Ease, USA). Statistical analysis
was carried out by generating polynomial models including
interaction and quadratic terms as well. After the analysis of
statistical parameters involving coefﬁcient of variation (CV)
and regression coefﬁcient (R2), the best ﬁtting model was cho-
sen. Analysis of variance (ANOVA) was applied to determine
signiﬁcant factors of the experiments. F test and p-values were
also calculated and evaluated.
The following mathematical model equation shows the
effects of various independent variables and their interaction:
Y ¼ b0 þ b1X1 þ b2X2 þ b12X1X2 þ b11X21 þ b22X22; ð7Þ
in which Y is the response, b0 is the intercept, and bi is the
estimated coefﬁcient of factors (X1, X2). X1, X2 are the main
effects. X1X2 is the interaction term, how responses change
when factors are changed simultaneously. X2 is the quadratic
effect to evaluate non-linearity.3. Results and discussion
3.1. Comparative physical study of different types of L-HPCs
3.1.1. Microscopic examination
Digital photo analysis revealed different shapes of L-HPCs
depicted by Fig. 2. L-HPC 11 particles had a thin, longitudinal
shape, while L-HPC B1 formed similar to spheroidal particles.
Sphericity of L-HPC 11 was 0.186 ± 0.082, while in the case of
L-HPC B1 it was 0.4802 ± 0.183.
Particle sizes varied also in comparison of the two L-HPCs.
The 50 largest particle sizes of examined particles were
44.01 ± 10.59 lm in the case of L-HPC B1 compared to L-
HPC 11 with 246.35 ± 82.03 lm size.
Figure 2 Microscopic snapshots of (a) L-HPC 11 and (b) L-HPC B1 particles.
Table 5 Data of ﬂoating lag time (tlag) and ﬂoating time (tf).
Exp. No. tlag (s) tf (min)
PFS01 6.44 ± 5.19 21.70 ± 4.56
PFS02 343.00 ± 28.99 240.00 ± 0.00
PFS03 0.00 ± 0.00 7.13 ± 0.47
PFS04 507.16 ± 100.35 240.00 ± 0.00
PFS05 0.00 ± 0.00 3.91 ± 0.28
PFS06 107.16 ± 75.77 240.00 ± 0.00
PFS07 109.20 ± 89.32 240.00 ± 0.00
PFS08 16.69 ± 1.58 240.00 ± 0.00
PFS09 520.30 ± 20.79 240.00 ± 0.00
PFS10 16.02 ± 6.58 28.63 ± 1.08
PFS11 356.55 ± 47.07 240.00 ± 0.00
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Over the study period (1 h) 50 mg pure disintegrants were
tested. Both L-HPCs behaved similarly having intense water
uptake in both media (water and hydrochloric acid). Fig. 3
shows the wettability in the function of time in distilled water
and 0.1 M HCl. At the end of the ﬁrst minute, both L-HPCs
immersed into distilled water absorbed more than 90% of
water compared to the water uptake during 1 h (L-HPC B1:
91.24 ± 1.02%, L-HPC 11: 93.83 ± 1.02%). In hydrochloric
acid, liquid absorption was similar to distilled water with a rel-
atively small decrease after 60 s (L-HPC B1: 89.05 ± 2.89%,
L-HPC 11: 92.77 ± 1.59%). L-HPC B1 had higher total wet-
tability than L-HPC 11 showed in Table 3. Decrease of wetta-
bility could be noticed in 0.1 M HCl compared to distilled
water at both L-HPC types. In the case of L-HPC 11, higher
rate of water uptake could be achieved with less amount of
medium absorbed at the end of examination compared to L-
HPC B1.
3.1.3. Flowability
Both Carr index and Hausner ratio showed better ﬂowability
properties for L-HPC B1 compared to L-HPC 11. Difference
could be detected not only in ratios but also between tapped
(qt) and bulk (qb) densities of the L-HPC B1
(qb = 0.4964 ± 0.0115, qt = 0.5908 ± 0.0026) and L-HPC
11 (qb = 0.3564 ± 0.0076, qt = 0.4428 ± 0.0013). Measure-
ments of angles of repose indicated the same relation. Results
are represented in Table 4.
Responses evinced that ﬂow properties of L-HPCs not
markedly differed in comparison in spite of their different
shape parameters and particle sizes.Table 3 Total wettability of L-HPC 11 and L-HPC B1.
Total wettability
of 50 mg L-HPCs
In distilled
water (mg)
In 0.1 M
HCl (mg)
L-HPC 11 483.7 ± 22.8 451.0 ± 17.4
L-HPC B1 522.7 ± 36.6 480.0 ± 39.6
Table 4 Flow characteristics of L-HPC 11 and L-HPC B1.
Carr index Hausner ratio Angle of repose ()
L-HPC 11 22.91 ± 0.32 1.24 ± 0.04 48.77 ± 1.67
L-HPC B1 19.05 ± 2.31 1.19 ± 0.02 39.24 ± 0.863.2. Floating lag time and ﬂoating time
Basic concept for the ﬂotation of the tablets was their 8%
sodium hydrogen carbonate content as a gas-forming agent
blended with sodium alginate as hydrogel matrix in order to
entrap the gas inside the tablet. This process was controlled
by the varying L-HPC content, which inﬂuenced the ﬂoating
lag time (tlag) and ﬂoating time (tf) shown in Table 5.
The best ﬁtting model for the ﬂoating lag time data was the
linear model (p< 0.01). Values of tlag indicate that lower level
of sodium alginate (0.5%) and various concentrations of L-
HPCs resulted in lower ﬂoating lag time for tablets. The only
signiﬁcant factor in this experiment was sodium alginate
(p< 0.01). Result showed that higher sodium alginate content
led to the increase of tlag. It is supposed that sodium alginate in
increased concentration leads to formation of alginic acid layerPFS12 0.00 ± 0.00 15.51 ± 2.96
PFS13 230.16 ± 11.87 240.00 ± 0.00
PFS14 0.00 ± 0.00 15.25 ± 1.89
PFS15 507.67 ± 161.30 240.00 ± 0.00
PFS16 273.45 ± 156.64 240.00 ± 0.00
PFS17 180.00 ± 51.64 240.00 ± 0.00
PFS18 106.14 ± 24.18 240.00 ± 0.00
PFS19 25.77 ± 6.53 35.74 ± 3.05
PFS20 238.16 ± 13.25 240.00 ± 0.00
PFS21 13.87 ± 3.25 17.23 ± 1.25
PFS22 417.22 ± 18.12 240.00 ± 0.00
PFS23 8.10 ± 2.62 13.34 ± 0.34
PFS24 330.33 ± 27.79 240.00 ± 0.00
PFS25 307.71 ± 174.70 240.00 ± 0.00
PFS26 344.00 ± 29.70 240.00 ± 0.00
PFS27 184.00 ± 24.64 240.00 ± 0.00
Figure 3 Wettability of L-HPC 11 and L-HPC B1 in distilled
water and in 0.1 M HCl.
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Thus due to the high polymer concentration, tablets with
higher weight require longer time to ﬂoat. In low concentra-
tion, sodium alginate swelled more rapidly enhanced by quick
water uptake of L-HPCs.
On ﬂoating time data, quadratic model was ﬁtted with high
signiﬁcance (p< 0.0001, R2 = 0.9992). Both independent
variables and their interaction showed acceptable signiﬁcance.
18 batches showed more than 4 h long buoyancy having 17.82–
35.15% sodium alginate. The shortest ﬂoating times were
recorded in the cases of 12.75% L-HPC 11 and L-HPCs 1:1
mixture. Presence of L-HPC 11 in tablets resulted in short
ﬂoating due to its faster disintegration.3.3. Determination of swelling capability
In case of ﬂoating drug delivery systems, the mechanism of
hydration and swelling capability are important parameters,
with which more speciﬁc physical evaluation can be per-
formed. Swelling capability may determine various parameters
of ﬂoating drug delivery systems including disintegration, dis-
solution as well as adhesion ability.
Mechanism of hydration was expounded by Bertram and
Bodmeier (2006), according to which water-absorbing ability
of hydrogels is inﬂuenced by hydrophilic groups in the chemi-
cal structure. Hydration of these hydrophilic groups results in
the swelling, namely the expansion and ordering of polymer
chains. At matrix tablets, swelling process requires certain time
to reach deeper layers to be hydrated, which is driven by the
passive diffusion. The theory of drug release from matrix tab-
lets was approached by Ju et al. (1995), describing that after
immersion of tablets, diffusion creates different hydration lay-
ers in tablets. Relatively dry core with low water content is fol-
lowed by more hydrated middle layer, which is surrounded by
a surface layer in contact with water. The surface layer is also
considered as an erosion front.
Swelling index (Si) represents the water uptake of tablets
standardized to the tablet weight. The result after 4 h showsthat tablets with the highest percent of sodium alginate and
L-HPCs had the highest swelling property (PFS04, PFS13,
PFS22) having Si more than 2.2. The lowest swelling indices
were recorded in the cases of PFS07, PFS16, PFS25 with lower
concentration of sodium alginate (17.83%) and 0.5% of L-
HPCs. Swelling indices from 1.9 to 2.2 could be detected in
the cases of PFS06, PFS15, PFS24 tablets with 35.15% sodium
alginate and 12.75% L-HPCs as well as at PFS08, PFS17,
PFS26 compositions having less sodium alginate and more
L-HPCs (17.83% sodium alginate and 25.0% L-HPCs).
Swelling was evaluated based on the experimental design.
Analysis of swelling at particular times revealed sodium algi-
nate as a signiﬁcant factor (p< 0.0006), while L-HPCs were
signiﬁcant from 120 min (p< 0.0301). At 30 and 60 min, L-
HPCs did not show signiﬁcant inﬂuence, then from 120 min
analysis concluded that swelling depends on the quantity of
L-HPCs, too.
In this case the categorical factor X3 was not rated to be sig-
niﬁcant. The most signiﬁcant ﬁtting on the linear model was
shown by the result of swelling at 4 h. Its equation is the
following:
Swellingð4hÞ ¼ 1:72þ 0:43X1 þ 0:12X2  3:455e0;003X31
 0:017X32 ð8Þ
The equation showed that factor X2 (L-HPCs) had less than
third inﬂuence on swelling after 4 h compared to factor X1
(sodium alginate).
3.4. Floating force study
Floating strength measurement was recorded in function of
time for 4 h. Two different ﬂoating patterns could be observed
within the samples: a rapidly disintegrating and an exponen-
tially increasing pattern. Two different types (PFS03/PFS04)
are illustrated in Fig. 4.
The two-factor model containing interactions was ﬁtted on
Fmax data with p< 0.0001. Signiﬁcant inﬂuence was observed
for both factors (sodium alginate and L-HPCs) (p< 0.0001)
and their interaction was also signiﬁcant (p= 0.0004). Cate-
gorical factor had no signiﬁcance. The ﬁnal equation relating
maximal ﬂoating forces as response becomes:
Fmax ¼ 2:05þ 0:53X1 þ 0:51X2 þ 0:18X31 þ 0:083X32
þ 0:54X1X2  0:42X1X31 þ 0:44X1X32
 0:013X2X31 þ 0:055X2X32 ð9Þ
On tFmax the data quadratic model was ﬁtted (p= 0.0009).
ANOVA indicated that the only factor which signiﬁcantly
inﬂuences tFmax was sodium alginate (p< 0.0001). The linear
model was ﬁtted on tF1/2 values with high signiﬁcance
(p= 0.0045) resulting sodium alginate to be the only signiﬁ-
cant factor (p= 0.0002). In both cases L-HPCs and categori-
cal factor were not signiﬁcant model terms.
3.5. Paracetamol dissolution study
Release of paracetamol of all EFTs was examined for 4 h. Dis-
solution of paracetamol of ﬂoating tablets containing L-HPCs
is shown in Fig. 5. The fastest dissolution was represented by
compositions containing 0.5% sodium alginate and 0.5%,
12.75% and 17.82% from particular L-HPCs. Rapid release
Figure 5 Release of paracetamol from EFTs containing L-HPC 11.
Figure 4 Floating force of (a) PFS03 (25.0% L-HPC 11, 0.5% sodium alginate) and (b) PFS04 (25.0% L-HPC 11, 35.15% sodium
alginate).
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since the weak alginic layer around the tablet was presumably
not strong enough to maintain the coherent structure and L-
HPCs could achieve disintegration of tablets.
The quadratic model was ﬁtted onto the curve of 4 h disso-
lution data. Final equation of dissolution at 4 h was:Figure 6 Inﬂuence of swelling capability on dissolution comparing P
(0.5% L-HPC 11/B1, 17.82% sodium alginate).Dissolution 4hð Þ ¼ 16:46 57:94X1 þ 2:29X2 þ 6:14X31
 3:50X32  1:57X1X2 þ 3:84X1X31
þ 1:32X1X32  0:81X2X31
þ 1:24X2X32 þ 73:62X21 þ 1:34X22 ð10ÞFS22 (25.0% L-HPC 11/B1, 35.15% sodium alginate) and PFS25
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2
(p< 0.0001) pointing that only the effect of sodium alginate
had inﬂuence on dissolution at 4 h. Concentration of L-HPC
was not signiﬁcant based on the analysis of variance
(ANOVA). Analysis of the quadratic model on dissolution at
60, 90, 120 and 180 min resulted in X1, X1
2 and categorical fac-
tors (L-HPC types) as signiﬁcant model terms (p 6 0.05).
These results were similar to the 4 h dissolution.
Statistical analysis of dissolution after 5, 10, 15, 20, 30 and
45 min showed different release behaviour compared to the
drug release proﬁle after 1 h. During this time interval L-
HPC showed disintegrant activity, which presumably inﬂu-
enced the dissolution of the drug substance. Categorical factor
in these six times was not signiﬁcant. The largest difference
between L-HPC types and their 1:1 mixture was observed at
15 min dissolution. More speciﬁc difference was between L-
HPC 11 and L-HPC B1, because their mixture mostly behaved
as L-HPC 11.
In 45 min period of time, not only difference between L-
HPC types was permanent, but also signiﬁcance of particular
L-HPCs on the quadratic model could be noticed, hence disso-
lution was inﬂuenced by the amount of L-HPCs in this time
interval. As an indicator of signiﬁcance on model, values of
p< 0.05 were acceptable. 45 min dissolution meant a special
point in the dissolution, since sodium alginate, L-HPCs, and
categorical factor all were signiﬁcant until this point. After this
time differences in dissolution between L-HPC types
disappeared.
Impact of sodium alginate and L-HPC types on dissolution
was evaluated by the analysis of ﬁnal equations of dissolution
at particular times, from which the largest impact of L-HPCs
was at 15 min dissolution:
Dissolution 15 minð Þ ¼ 6:85 52:21X1 þ 11:17X2
þ 2:30X31  2:79X32
 16:56X1X2  1:79X1X31
þ 3:24X1X32  1:59X2X31
þ 0:73X2X32 þ 53:34X21  5:64X22 ð11Þ
Equation also expresses interaction between L-HPC and
sodium alginate, which was only observed between 5 and
45 min.
Release of paracetamol was compared to the swelling
behaviour of EFTs in order to achieve a better approach
in the mechanism of drug release. Dissolution data were
assessed in function of swelling data for each composition
at the same sampling time. On evaluating the results, expo-
nential correlation was found, which conﬁrms that increase
in swelling enhances the dissolution of paracetamol. Fig. 6
shows the inﬂuence of the swelling on the dissolution of
PFS22 and PFS25 having the highest and lowest swelling
indices.4. Conclusions
In this study, 27 different EFT tablet samples were successfully
prepared by using various amounts of sodium alginate, L-HPC
11 and L-HPC B1 as excipients and paracetamol as the active
pharmaceutical ingredient. Relevant, but small differences
were observed at the two L-HPC types during the physicalexaminations of the substances. In these tests, L-HPC 11 had
lower water uptake and slightly worse ﬂowability, which may
be explicable due to its longitudinal shape and larger particle
size. Prepared tablets were further investigated from the view-
point of ﬂoating dosage forms. Analysis of ﬂoating lag time
values and times for maximal and half maximal ﬂoating force
coincided so that the only inﬂuencing factor was the amount of
sodium alginate. L-HPCs were detected to have impact on
maximal ﬂoating force and showed to behave differently.
Higher and lower ﬂoating force values could be noticed at L-
HPC B1 in compositions, while values of L-HPC 11 produced
smaller maximal ﬂoating force. Effect of L-HPCs on disinte-
gration could be observed in paracetamol release examinations
in the ﬁrst hours, which coincided with the results of swelling
capabilities. Function of release and swelling tests showed
exponential increasing relationship. Though L-HPCs did not
affect the paracetamol release after 1 h, swelling after 1 h
showed to have an inverse inﬂuence on swelling with different
L-HPCs. In both results, sodium alginate had signiﬁcant inﬂu-
ence. During the experiments and their evaluation a coopera-
tive effect of L-HPCs and sodium alginate was revealed,
which resulted in the liquid uptake without disintegrating
effect, enhancing the entrapment of the developing carbon
dioxide in the ﬂoating system. Our results may stand as a basis
for further studies in the ﬁeld of development and optimization
of disintegrating ﬂoating dosage forms.
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